首页 > 市场调查报告书 > 消费品

宠物产品

市场调查报告书

商品编码

1448742

全球宠物照护糖尿病药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Pet Care Diabetes Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球宠物照护糖尿病药物市场需求预计将从 2023 年的 750.11 万美元达到 2032 年近 1429.73 万美元的市场规模，2024-2032 年研究期间CAGR为 7.43%。

宠物照顾糖尿病药物市场涉及治疗影响宠物（包括狗和猫）的糖尿病的药物。宠物糖尿病是一种可以透过药物、胰岛素治疗和饮食改变来控制的疾病，就像人类一样。兽医可能会开立胰岛素和其他旨在调节血糖水平的药物来控制宠物的糖尿病。

市场动态

宠物照护糖尿病药物市场受到多种因素的推动，导致对专业兽药的需求增加。全球宠物趋势的不断增长是一个重要的推动因素，越来越多的人将宠物视为不可或缺的家庭成员。宠物主人对动物健康，特别是糖尿病等疾病的认识不断提高，导致诊断率提高，并愿意寻求先进的治疗方法。兽医学的不断进步，包括开发新的和更有效的药物，有助于市场的成长。宠物的人性化以及对其医疗保健的投资意愿不断增强，进一步推动了针对动物的糖尿病药物的需求。药物配方、给药方法和监测设备的创新，以及兽医保健基础设施的改进，在加强宠物糖尿病的诊断和管理方面发挥关键作用。製药公司、兽医诊所和研究机构之间的合作，加上支持性法规，也有助于宠物照护糖尿病药物市场的动态扩张。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球宠物照护糖尿病药物市场的各个细分市场进行了包容性评估。宠物照护糖尿病药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

宠物照护糖尿病药物市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

胰岛素药物
SGLT2 抑制剂
其他的

依动物类型

猫
小狗

按最终用户

兽医医院药房
零售药局
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲宠物护理糖尿病药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。宠物照护糖尿病药物市场的主要参与者包括勃林格殷格翰国际有限公司、Elanco、默克动物保健公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：宠物照护糖尿病药物公司的竞争格局

宠物照护糖尿病药物市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Boehringer Ingelheim International GmbH

公司简介
公司收入
产品
最近的发展

Elanco

公司简介
公司收入
产品
最近的发展

Merck Animal Health

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113598

The global demand for Pet Care Diabetes Drugs Market is presumed to reach the market size of nearly USD 1429.73 MN by 2032 from USD 750.11 MN in 2023 with a CAGR of 7.43% under the study period 2024 - 2032.

The Pet Care Diabetes Drugs market involves drugs that treat diabetes mellitus affecting pets, including dogs and cats. Diabetes in pets is a condition that may be managed with medications, insulin therapy, and dietary changes, much like in humans. Insulin and other medications designed to regulate blood sugar levels may be prescribed by veterinarians to manage diabetes in pets.

MARKET DYNAMICS

The Pet Care Diabetes Drugs market is driven by various factors contributing to the increased demand for specialized veterinary pharmaceuticals. The growing global trend of pet ownership is a significant driver, with more individuals considering pets as integral family members. Rising awareness among pet owners regarding animal health, particularly conditions like diabetes, has led to higher diagnosis rates and a willingness to seek advanced treatments. Ongoing advancements in veterinary medicine, including the development of new and more effective drugs, contribute to market growth. The humanization of pets and the increasing willingness to invest in their healthcare further boost the demand for diabetes drugs tailored for animals. Innovations in drug formulations, delivery methods, and monitoring devices, along with improvements in veterinary healthcare infrastructure, play key roles in enhancing the diagnosis and management of diabetes in pets. Collaborations between pharmaceutical companies, veterinary clinics, and research institutions, coupled with supportive regulations, also contribute to the dynamic expansion of the pet care diabetes drugs market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pet care diabetes drugs. The growth and trends of pet care diabetes drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pet care diabetes drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Insulin Drugs
SGLT2 Inhibitors
Others

By Animal Type

Cats
Dogs

By End-User

Vet Hospital Pharmacies
Retail Pharmacies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pet Care Diabetes Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pet Care Diabetes Drugs market include Boehringer Ingelheim International GmbH, Elanco, Merck Animal Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PET CARE DIABETES DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Animal Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Insulin Drugs Historic and Forecast Sales by Regions
5.5 SGLT2 Inhibitors Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY ANIMAL TYPE

6.1 Overview by Animal Type
6.2 Historical and Forecast Data
6.3 Analysis by Animal Type
6.4 Cats Historic and Forecast Sales by Regions
6.5 Dogs Historic and Forecast Sales by Regions

7 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Vet Hospital Pharmacies Historic and Forecast Sales by Regions
7.5 Retail Pharmacies Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL PET CARE DIABETES DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PET CARE DIABETES DRUGS COMPANIES

9.1. Pet Care Diabetes Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PET CARE DIABETES DRUGS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Boehringer Ingelheim International GmbH
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Elanco
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Merck Animal Health
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments